Back
ESC Professional Premium Access

Bleeding risk prediction in a large cohort of patients with atrial fibrillation and cancer: A nationwide cohort study

Session: Oral anticoagulation in real life
Topic: Oral Anticoagulation
Speaker: Associate Professor D. Pastori (Rome, IT)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Associate Professor Daniele Pastori

Sapienza University of Rome, Rome (Italy)
1 presentation
0 follower

7 more presentations in this session

Body mass index from the RE-LY trial: further evidence of the obesity paradox

Speaker: Doctor M. Jacobs (Stony Brook, US)

Access
Abstract
Slides
Like
Thumbnail

Management of atrial fibrillation by different medical specialties in the UK: AF-GEN-UK study

Speaker: Doctor A. Shantsila (Liverpool, GB)

Access
Abstract
Slides
Like
Thumbnail

Oral anticoagulation therapy in atrial fibrillation patients with advanced chronic kidney disease: CODE-AF Registry

Speaker: Professor H. Yu (Seoul, KR)

Access
Abstract
Slides
Like
Thumbnail

Patterns of anticoagulant prescribing and renal function changes in patients with atrial fibrillation

Speaker: Doctor C. Olesovsky (Toronto, CA)

Access
Abstract
Slides
Like
Thumbnail

Comparative validation of the HAS-BLED and the GARFIELD-AF bleeding risk scores in Asian patients with atrial fibrillation: a report from the COOL-AF registry

Speaker: Doctor P. Chichareon (Hat Yai, TH)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Oral anticoagulation in real life

Speakers: Associate Professor D. Pastori, Doctor M. Jacobs, Doctor A. Shantsila, Professor H. Yu, Doctor C. Olesovsky...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources